This document establishes the rigorous criteria for content validation, terminology standardization, and clinical applicability assessment within the Neuroscience domain of the Aevum Encyclopedia. It ensures that all entries meet academic-grade accuracy and provide actionable frameworks for translational research.
1. Scope & Purpose
The integration of neuroscientific data into clinical workflows requires unambiguous standards to mitigate risk and maximize utility. This standard governs the creation, review, and classification of content related to brain structure, function, pathology, and therapeutic intervention.
Compliance is mandatory for all articles tagged under Neuroscience, Neurology, Psychiatry, and Neuroengineering within the Aevum ecosystem.
2. Terminology Standards
Precision in nomenclature is the foundation of scientific communication. All entries must adhere to the following lexicons:
2.1 NeuroNames Adherence
Anatomical structures must reference the NeuroNames (BrainInfo) database maintained by the NIH/NINDS. Abbreviations are discouraged in primary headings but permitted in tables with full definitions.
"The term 'limbic system' is acceptable in historical contexts but must be qualified by modern network-based definitions (e.g., salience network, default mode network) to avoid anatomical ambiguity." — Aevum Editorial Guideline NG-104
2.2 Clinical Nomenclature
- Diagnostic criteria must align with ICD-11 and DSM-5-TR where applicable.
- Pharmacological agents must list generic names first, followed by brand names in parentheses.
- Symptom descriptions must use SNOMED CT codes for interoperability.
3. Neuroscientific Accuracy
Content claiming structural, functional, or connectivity data must satisfy quantitative validation thresholds.
3.1 Imaging Protocols
Descriptions of neuroimaging findings must specify preprocessing pipelines. Articles referencing fMRI must disclose:
| Parameter | Required Specification | Acceptable Range |
|---|---|---|
| Resolution | Voxel size (mm³) | 1.5mm³ – 3.0mm³ (Clinical) / <1mm³ (Research) |
| Normalization | Template space | MNI152, Talairach, or Subject-Specific |
| Correction | Multiplicity correction | FWE, FDR, or TFCE (must be stated) |
3.2 Connectomics Metrics
Claims regarding structural or functional connectivity must report confidence intervals and thresholding methods. Graph theoretical metrics (e.g., small-worldness, modularity) require code availability or detailed algorithmic descriptions.
Content describing diagnostic algorithms or treatment protocols must be explicitly flagged with a Clinical Disclaimer. Aevum content is for informational purposes and does not constitute medical advice.
4. Clinical Translation
For entries bridging basic research and clinical practice, the following translation criteria apply:
4.1 Evidence Grading
All therapeutic recommendations must include an evidence level according to the GRADE system:
- Level A: High-quality evidence from RCTs or meta-analyses.
- Level B: Moderate-quality evidence or extrapolated Level A.
- Level C: Low-quality evidence or expert consensus.
- Level D: Theoretical or preclinical only.
4.2 Bench-to-Bedside Validation
Entries covering novel biomarkers or neurotechnologies must address:
- Reproducibility across independent cohorts.
- Regulatory status (FDA/EMA clearance or approval).
- Limitations in diverse populations (age, sex, ethnicity).
5. Ethical & Safety Criteria
Neuroscience touches sensitive domains of privacy and autonomy. Content must:
- Avoid neuro-deterministic language unless supported by longitudinal data.
- Disclose data provenance and IRB approval for human studies.
- Address potential misuse of neurotechnologies (e.g., cognitive enhancement, neural data privacy).
6. Verification Workflow
Compliance with this standard is enforced through the Aevum Triple-Verification Protocol:
- Automated Check: NLP-based consistency and terminology validation.
- Peer Review: Double-blind review by at least two domain experts.
- Editorial Final: Sign-off by the Senior Neurosciences Editor.
Articles failing verification are flagged for revision or demoted to "Draft" status until compliance is achieved.
7. References
[1] NeuroNames. National Institute of Neurological Disorders and Stroke. 2024.
[2] DSM-5-TR. American Psychiatric Association. 2022.
[3] GRADE Working Group. J Clin Epidemiol. 2023.
[4] Aevum Encyclopedia Editorial Policy. v12.0. 2025.